TY - JOUR T1 - Stakeholders’ Perspectives on the Application of New Diagnostic Devices for Urinary Schistosomiasis in Oyo State, Nigeria: A Q-Methodology Approach JF - Global Health: Science and Practice JO - GLOB HEALTH SCI PRACT DO - 10.9745/GHSP-D-21-00780 AU - Karlheinz Tondo Samenjo AU - Michel Bengtson AU - Adeola Onasanya AU - Juan Carlo Intriago Zambrano AU - Opeyemi Oladunni AU - Oladimeji Oladepo AU - Jo van Engelen AU - Jan-Carel Diehl Y1 - 2022/08/04 UR - http://www.ghspjournal.org/content/early/2022/08/03/GHSP-D-21-00780.abstract N2 - Key FindingsQ-methodology served as a rigorous tool to identify the needs and product-service design requirements of stakeholders throughout the health care system.Stakeholders at various levels of the health care system shared that new diagnostic devices for schistosomiasis should: be available at the point of need and require minimal infrastructure to increase diagnostic capacity and surveillance, particularly in rural or distant settings; be less expensive to make diagnostic testing more affordable; and be able to identify infection status before treatment to support the identification and prioritization of patients or areas in need of treatment.Key ImplicationsMedical device designers and technology companies should ensure the development of new diagnostic devices for health care facilities with minimal infrastructure; these devices should be affordable and deployable, as well as able to identify infection status before treatment.Health care systems and community stakeholders in Nigeria should continuously participate and collaborate with the design industry in the human-centered design process of new diagnostic devices to ensure that the viewpoints of stakeholders at various levels of the health care system are explored and considered in the design process.Urinary schistosomiasis is a waterborne parasitic infection caused by Schistosoma haematobium that affects approximately 30 million people annually in Nigeria. Treatment and eradication of this infection require effective diagnostics. However, current diagnostic tests have critical shortcomings and consequently are of limited value to stakeholders throughout the health care system who are involved in targeting the diagnosis and subsequent control of schistosomiasis. New diagnostic devices that fit the local health care infrastructure and support the different stakeholder diagnostic strategies remain a critical need. This study focuses on understanding, by means of Q-methodology, the context of use and application of a new diagnostic device that is needed to effectively diagnose urinary schistosomiasis in Oyo State, Nigeria. Q-methodology is a technique that investigates subjectivity by exploring how stakeholders rank-order opinion statements about a phenomenon. In this study, 40 statements were administered to evaluate stakeholder perspectives on the context of use and application of potential new diagnostic devices and how these perspectives or viewpoints are shared with other stakeholders. Potential new diagnostic devices will need to be deployable to remote or distant communities, be affordable, identify and confirm infection status before treatment in patients whose diagnosis of urinary schistosomiasis is based on self-reporting, and equip health care facilities with diagnostic devices optimized for the local setting while requiring local minimal infrastructural settings. Similarly, the context of use and application of a potential new diagnostic device for urinary schistosomiasis is primarily associated with the tasks stakeholders throughout the health care system perform or procedures employed. These findings will guide the development of new diagnostic devices for schistosomiasis that match the contextual landscape and diagnostic strategies in Oyo. ER -